U.S. pharmaceutical supply chain Archives - CDR

U.S. pharmaceutical supply chain requires overhaul says business group expert forum

July 22, 2021 by Chain Drug Review Business Group on Health, U.S. pharmaceutical supply chain Leading Headlines, Pharmacy

WASHINGTON – The U.S. pharmaceutical supply chain must be remodeled to address long-standing conflicts and achieve a delivery model marked by transparency, affordability and access, a multistakeholder working committee created by Business Group on Health recommended today to industry leaders and government regulators. The committee, composed of employers, health plans, pharmacy benefit managers, pharmaceutical manufacturers,

HDA, NACDS CEOs: Rx importation not worth risk

May 8, 2017 by CDR Blog and Chain Drug Review Drug Supply Chain Security Act, DSCSA, Healthcare Distribution Alliance, importation of prescription drugs, John Gray, National Association of Chain Drug Stores, PDUFA, Prescription Drug User Fee Act, Steve Anderson, The Hill, U.S. pharmaceutical supply chain CDR Blog

Efforts to promote the importation of prescription drugs — seen by some as one way to mitigate the escalating cost of medications — could compromise the safety of the U.S. pharmaceutical supply chain, according to HDA’s John Gray and NACDS’ Steve Anderson. In a blog post on Monday for the policy journal The Hill, Gray,